Compare Aurobindo Pharma with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ALEMBIC LTD - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA ALEMBIC LTD AUROBINDO PHARMA/
ALEMBIC LTD
 
P/E (TTM) x 13.8 63.7 21.6% View Chart
P/BV x 2.5 2.6 97.5% View Chart
Dividend Yield % 0.4 0.4 105.9%  

Financials

 AUROBINDO PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
ALEMBIC LTD
Mar-18
AUROBINDO PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs83072 1,152.8%   
Low Rs52734 1,554.9%   
Sales per share (Unadj.) Rs333.94.7 7,103.4%  
Earnings per share (Unadj.) Rs40.46.1 661.2%  
Cash flow per share (Unadj.) Rs51.86.2 828.7%  
Dividends per share (Unadj.) Rs2.500.20 1,250.0%  
Dividend yield (eoy) %0.40.4 97.5%  
Book value per share (Unadj.) Rs237.140.7 583.1%  
Shares outstanding (eoy) m585.91267.03 219.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.011.3 18.0%   
Avg P/E ratio x16.88.7 193.8%  
P/CF ratio (eoy) x13.18.5 154.6%  
Price / Book Value ratio x2.91.3 219.8%  
Dividend payout %6.23.3 189.1%   
Avg Mkt Cap Rs m397,56914,139 2,811.8%   
No. of employees `00017.9NA-   
Total wages/salary Rs m25,849207 12,463.2%   
Avg. sales/employee Rs Th10,956.9NM-  
Avg. wages/employee Rs Th1,447.7NM-  
Avg. net profit/employee Rs Th1,324.3NM-  
INCOME DATA
Net Sales Rs m195,6361,255 15,586.0%  
Other income Rs m1,553370 419.6%   
Total revenues Rs m197,1891,625 12,131.7%   
Gross profit Rs m39,519111 35,571.0%  
Depreciation Rs m6,68038 17,670.6%   
Interest Rs m2,6262 154,470.6%   
Profit before tax Rs m31,767442 7,190.4%   
Minority Interest Rs m270-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m-8810-   
Tax Rs m7,26924 30,348.6%   
Profit after tax Rs m23,6451,630 1,450.7%  
Gross profit margin %20.28.9 228.2%  
Effective tax rate %22.95.4 422.1%   
Net profit margin %12.1129.8 9.3%  
BALANCE SHEET DATA
Current assets Rs m153,6451,867 8,229.1%   
Current liabilities Rs m120,429591 20,370.3%   
Net working cap to sales %17.0101.6 16.7%  
Current ratio x1.33.2 40.4%  
Inventory Days Days13594 143.4%  
Debtors Days Days6474 86.6%  
Net fixed assets Rs m103,9091,791 5,802.0%   
Share capital Rs m586534 109.7%   
"Free" reserves Rs m138,32210,324 1,339.9%   
Net worth Rs m138,90810,858 1,279.3%   
Long term debt Rs m1,80041 4,367.7%   
Total assets Rs m264,54411,591 2,282.4%  
Interest coverage x13.1260.9 5.0%   
Debt to equity ratio x00 341.4%  
Sales to assets ratio x0.70.1 682.9%   
Return on assets %9.914.1 70.5%  
Return on equity %17.015.0 113.4%  
Return on capital %23.815.2 156.9%  
Exports to sales %49.61.5 3,211.0%   
Imports to sales %18.821.0 89.5%   
Exports (fob) Rs m97,09119 500,470.1%   
Imports (cif) Rs m36,741263 13,952.0%   
Fx inflow Rs m97,31619 501,630.9%   
Fx outflow Rs m40,589264 15,385.2%   
Net fx Rs m56,727-244 -23,208.9%   
CASH FLOW
From Operations Rs m16,220236 6,878.8%  
From Investments Rs m-28,768-224 12,843.0%  
From Financial Activity Rs m19,191-27 -72,145.1%  
Net Cashflow Rs m6,656-15 -44,975.7%  

Share Holding

Indian Promoters % 54.1 64.0 84.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.0 0.2 3,975.0%  
FIIs % 27.7 9.7 285.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.2 26.1 39.1%  
Shareholders   69,601 54,701 127.2%  
Pledged promoter(s) holding % 8.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SHASUN PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  WYETH LTD  

Compare AUROBINDO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 428 Points Higher; Energy and Healthcare Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended their trading session on a positive note today.

Related Views on News

NIPPON LIFE INDIA AMC Surges by 10%; BSE 500 Index Up 1.2% (Market Updates)

Feb 19, 2020 | Updated on Feb 19, 2020

NIPPON LIFE INDIA AMC share price has surged by 10% and its current market price is Rs 433. The BSE 500 is up by 1.2%. The top gainers in the BSE 500 Index are NIPPON LIFE INDIA AMC (up 10.0%) and AUROBINDO PHARMA (up 19.0%). The top losers are OBEROI REALTY and FINOLEX CABLES .

HERITAGE FOOD Surges by 11%; BSE 500 Index Up 1.1% (Market Updates)

Feb 19, 2020 | Updated on Feb 19, 2020

HERITAGE FOOD share price has surged by 11% and its current market price is Rs 379. The BSE 500 is up by 1.1%. The top gainers in the BSE 500 Index are HERITAGE FOOD (up 11.3%) and AUROBINDO PHARMA (up 19.4%). The top losers are PHOENIX MILL and HERO MOTOCORP .

BHARAT DYNAMICS Surges by 10%; BSE 500 Index Up 0.9% (Market Updates)

Feb 19, 2020 | Updated on Feb 19, 2020

BHARAT DYNAMICS share price has surged by 10% and its current market price is Rs 296. The BSE 500 is up by 0.9%. The top gainers in the BSE 500 Index are BHARAT DYNAMICS (up 10.2%) and AUROBINDO PHARMA (up 17.9%). The top losers are APOLLO TYRES and SUNDRAM FASTENERS .

VODAFONE IDEA Surges by 12%; BSE 500 Index Up 0.7% (Market Updates)

Feb 19, 2020 | Updated on Feb 19, 2020

VODAFONE IDEA share price has surged by 12% and its current market price is Rs 3. The BSE 500 is up by 0.7%. The top gainers in the BSE 500 Index are VODAFONE IDEA (up 11.6%) and AUROBINDO PHARMA (up 17.9%). The top losers are INFOSYS and TCS .

AUROBINDO PHARMA Surges by 14%; BSE HEALTHCARE Index Up 1.5% (Market Updates)

Feb 19, 2020 | Updated on Feb 19, 2020

AUROBINDO PHARMA share price has surged by 14% and its current market price is Rs 594. The BSE HEALTHCARE is up by 1.5%. The top gainers in the BSE HEALTHCARE Index is AUROBINDO PHARMA (up 14.5%). The top losers are ERIS LIFESCIENCES LIMITED (down 0.1%) and CAPLIN POINT (down 0.1%).

More Views on News

Most Popular

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

How to Become a One Stock Crorepati(Profit Hunter)

Feb 6, 2020

A little known Indian stock that is set to turn around its own fortunes, and your wealth, if you just have the foresight to get in on time...

Will Algo Traders Take Away All Your Profits?(Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

How to Use Stop Losses in Your Trading(Fast Profits Daily)

Feb 13, 2020

There's more to stop losses than just limiting a trading loss. Find out more...

No Change in My Long-Term View on the Rebirth of India Stocks(The 5 Minute Wrapup)

Feb 6, 2020

Why the recent post budget volatility has not affected my bullish view on the Rebirth of India stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Feb 19, 2020 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - ALKEM LABORATORIES COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS